Wanbury Quarterly Results for Trading Insights

WANBURY • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹20 Cr
QMar 2025
Quarterly Results

Wanbury Quarterly Results Key Highlights

  • Revenue of ₹174 Cr in Mar 2025 (+6.1% vs Jun 2025, +4.8% vs Mar 2024)
  • Net Profit of ₹20 Cr in Mar 2025 (+42.9% vs Jun 2025, -41.2% vs Mar 2024)
  • EBITDA of ₹32 Cr in Mar 2025 (+28.0% vs Jun 2025)
  • Operating Margin of 17.0% in Mar 2025 (+2.0pp vs Jun 2025)
  • Earnings Per Share of ₹6.18 in Mar 2025 (+50.0% vs Jun 2025)

Wanbury Quarterly Results Analysis

Metric Mar 2025 Jun 2025 Sept 2024 Mar 2024 Jun 2024 QoQ YoY
Revenue (₹ Cr) 174 164 163 166 132 6.1% 4.8%
Net Profit (₹ Cr) 20 14 8 34 1 - -
EBITDA (₹ Cr) 32 25 22 45 12 - -
EPS (₹) 6.18 4.12 2.44 10.28 0.32 - -
Operating Margin (%) 17.0% 15.0% 12.0% 13.0% 8.0% - -

Wanbury Share Price Trend Around Quarterly Results

Visualize Wanbury's 1-year price movement across quarterly results — ideal for logging trades in Wanbury share price chart using Tickjournal. All values in ₹.

Related Pages for Wanbury

Additional stock information and data for WANBURY

Wanbury market cap
Wanbury annual reports
WANBURY share price nse chart
Wanbury P/E valuation
WANBURY yearly price range
Wanbury valuation methods
WANBURY value investing
WANBURY book value comparison

Profitability Ratios

Profit Margin 11.5%
EBITDA Margin 18.4%
Operating Margin 17.0%
ROE (Annual) 135.6%

Balance Sheet Highlights

Total Assets ₹414 Cr
Total Equity ₹59 Cr
Current Assets ₹193 Cr
Current Liabilities ₹180 Cr

Cash Flow Analysis

Operating Cash Flow ₹26 Cr
Investing Cash Flow ₹-51 Cr
Financing Cash Flow ₹26 Cr
Net Cash Flow ₹1 Cr

Current Market Data

Current Price ₹224.67
Exchange NSE
Last Updated Jan 06, 2026

Revenue Trend (₹ Cr)

Mar 2024 166
Sept 2024 163
Jun 2025 164
Mar 2025 174

Net Profit Trend (₹ Cr)

Mar 2024 34
Sept 2024 8
Jun 2025 14
Mar 2025 20

Operating Margin Trend (%)

Mar 2024 13.0%
Sept 2024 12.0%
Jun 2025 15.0%
Mar 2025 17.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Wanbury quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹412,613.60 Cr 1760.2 14,875 3,125 +10.8% - 21.0% 135.4
Divis Laboratories
Sept 2025 		₹169,700.80 Cr 6642.5 2,860 689 +7.1% - 24.1% 255.8
Torrent Pharmaceuti…
Sept 2025 		₹129,171.09 Cr 3936.8 3,219 591 +11.3% - 18.4% 224.4
Cipla
Sept 2025 		₹121,238.47 Cr 1530.8 7,716 1,353 +12.0% - 17.5% 91.5
Dr Reddys Laborator…
Sept 2025 		₹104,570.84 Cr 1256.2 9,135 1,337 +1.1% - 14.6% 77.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores